SeaStar Medical (NASDAQ:ICU) Releases Earnings Results, Misses Expectations By $0.01 EPS

SeaStar Medical (NASDAQ:ICU) posted its quarterly earnings data on Thursday. The company reported ($0.90) earnings per share for the quarter, missing the consensus estimate of ($0.89) by ($0.01), Zacks reports. The company had revenue of $0.07 million for the quarter, compared to analysts’ expectations of $0.15 million.

SeaStar Medical Stock Down 22.7 %

Shares of ICU opened at $1.70 on Friday. The stock’s fifty day simple moving average is $1.87 and its 200-day simple moving average is $2.62. The firm has a market capitalization of $11.00 million, a PE ratio of -0.15 and a beta of -0.97. SeaStar Medical has a 12-month low of $1.50 and a 12-month high of $20.70.

SeaStar Medical Company Profile

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.